Elevar Therapeutics
Korea - Seoul
BiotechnologyFocus: Oncology Treatments
Elevar Therapeutics is a life sciences company focused on Oncology Treatments.
Oncology
Open Jobs
2
Pipeline & Clinical Trials
Rivoceranib
HealthyClinical Trials (1)
NCT05287360A Study Comparing Four Different Rivoceranib Tablets in Healthy Participants
Phase 1Apatinib
Advanced MalignanciesClinical Trials (1)
NCT03407976Apatinib With Pembrolizumab in Previously Treated Advanced Malignancies
Phase 1Rivoceranib
Metastatic Colorectal CancerClinical Trials (1)
NCT04073615A Study of Rivoceranib and Trifluridine/Tipiracil for Metastatic Colorectal Cancer (mCRC)
Phase 1Apatinib
CancerClinical Trials (1)
NCT03396211A Study to Evaluate Apatinib (Also Known as Rivoceranib) Plus Nivolumab in Participants With Unresectable or Metastatic Cancer
Phase 1Rivoceranib
Gastric CancerClinical Trials (1)
NCT03707028A Study to Evaluate Safety, Tolerability, and Efficacy Profile of Rivoceranib With Paclitaxel in Advanced Gastric or Gastroesophageal Junction Cancer
Phase 1/2RLY-4008
FGFR2 AmplificationClinical Trials (1)
NCT04526106REFOCUS: A First-in-Human Study of Highly Selective FGFR2 Inhibitor, RLY-4008, in Patients With ICC and Other Advanced Solid Tumors
Phase 1/2Phase 1/2
Clinical Trials (1)
NCT01497704Dose-Escalation and Safety Trial of YN968D1
Phase 1/2Rivoceranib
Metastatic Olfactory NeuroblastomaClinical Trials (1)
NCT06308575A Phase II Study of Rivoceranib for Patients With Recurrent or Metastatic Olfactory Neuroblastoma
Phase 2Lirafugratinib
FGFR2 Gene Fusion/RearrangementClinical Trials (1)
NCT07359820A Study of Lirafugratinib in Non-CCA Solid Tumors With FGFR2 Fusion or Rearrangement
Phase 2Rivoceranib
Adenoid Cystic CarcinomaClinical Trials (1)
NCT04119453A Study to Evaluate the Efficacy and Safety of Rivoceranib in Participants With Recurrent or Metastatic Adenoid Cystic Carcinoma (ACC)
Phase 2Rivoceranib
Gastric CancerClinical Trials (1)
NCT03042611A Study to Evaluate Rivoceranib Plus Best Supportive Care Compared to Placebo Plus Best Supportive Care in Participants With Gastric Cancer
Phase 3Open Jobs (2)
Interview Prep Quick Facts
Founded: 2024
Portfolio: 11 clinical trials
Open Roles: 2 active jobs
Hiring Trend
Stable
2
Open Roles
+0
Added
-0
Filled/Removed
Based on last 4 crawl cycles